March 4 (Reuters) - The U.S. Food and Drug Administration's top operations official, Barclay Butler, will retire in the coming months, Endpoints News reported on Wednesday, citing an internal email from FDA Commissioner Marty Makary.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.